Memory Impairment Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 62 pages | ID: M092D2E00280EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Memory Impairment Treatment in Global, including the following market information:

Global Memory Impairment Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Memory Impairment Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

HT-3951 Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Memory Impairment Treatment include F. Hoffmann-La Roche Ltd., Suven Life Sciences Ltd., Met P Pharma AG, Dart NeuroScience LLC., Omeros Corporation, Sunovion Pharmaceuticals Inc. and AbbVie Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Memory Impairment Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Memory Impairment Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Memory Impairment Treatment Market Segment Percentages, by Type, 2021 (%)

• HT-3951
• 2-PMPA
• Meldonium
• AC-253
• RO-4938581
• Others

Global Memory Impairment Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Memory Impairment Treatment Market Segment Percentages, by Application, 2021 (%)

• Clinic
• Hospital
• Others

Global Memory Impairment Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Memory Impairment Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Memory Impairment Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Memory Impairment Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• F. Hoffmann-La Roche Ltd.
• Suven Life Sciences Ltd.
• Met P Pharma AG
• Dart NeuroScience LLC.
• Omeros Corporation
• Sunovion Pharmaceuticals Inc.
• AbbVie Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Memory Impairment Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Memory Impairment Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MEMORY IMPAIRMENT TREATMENT OVERALL MARKET SIZE

2.1 Global Memory Impairment Treatment Market Size: 2021 VS 2028
2.2 Global Memory Impairment Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Memory Impairment Treatment Players in Global Market
3.2 Top Global Memory Impairment Treatment Companies Ranked by Revenue
3.3 Global Memory Impairment Treatment Revenue by Companies
3.4 Top 3 and Top 5 Memory Impairment Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Memory Impairment Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Memory Impairment Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Memory Impairment Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Memory Impairment Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Memory Impairment Treatment Market Size Markets, 2021 & 2028
  4.1.2 HT-3951
  4.1.3 2-PMPA
  4.1.4 Meldonium
  4.1.5 AC-253
  4.1.6 RO-4938581
  4.1.7 Others
4.2 By Type - Global Memory Impairment Treatment Revenue & Forecasts
  4.2.1 By Type - Global Memory Impairment Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Memory Impairment Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Memory Impairment Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Memory Impairment Treatment Market Size, 2021 & 2028
  5.1.2 Clinic
  5.1.3 Hospital
  5.1.4 Others
5.2 By Application - Global Memory Impairment Treatment Revenue & Forecasts
  5.2.1 By Application - Global Memory Impairment Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Memory Impairment Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Memory Impairment Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Memory Impairment Treatment Market Size, 2021 & 2028
6.2 By Region - Global Memory Impairment Treatment Revenue & Forecasts
  6.2.1 By Region - Global Memory Impairment Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Memory Impairment Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Memory Impairment Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Memory Impairment Treatment Revenue, 2017-2028
  6.3.2 US Memory Impairment Treatment Market Size, 2017-2028
  6.3.3 Canada Memory Impairment Treatment Market Size, 2017-2028
  6.3.4 Mexico Memory Impairment Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Memory Impairment Treatment Revenue, 2017-2028
  6.4.2 Germany Memory Impairment Treatment Market Size, 2017-2028
  6.4.3 France Memory Impairment Treatment Market Size, 2017-2028
  6.4.4 U.K. Memory Impairment Treatment Market Size, 2017-2028
  6.4.5 Italy Memory Impairment Treatment Market Size, 2017-2028
  6.4.6 Russia Memory Impairment Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Memory Impairment Treatment Market Size, 2017-2028
  6.4.8 Benelux Memory Impairment Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Memory Impairment Treatment Revenue, 2017-2028
  6.5.2 China Memory Impairment Treatment Market Size, 2017-2028
  6.5.3 Japan Memory Impairment Treatment Market Size, 2017-2028
  6.5.4 South Korea Memory Impairment Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Memory Impairment Treatment Market Size, 2017-2028
  6.5.6 India Memory Impairment Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Memory Impairment Treatment Revenue, 2017-2028
  6.6.2 Brazil Memory Impairment Treatment Market Size, 2017-2028
  6.6.3 Argentina Memory Impairment Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Memory Impairment Treatment Revenue, 2017-2028
  6.7.2 Turkey Memory Impairment Treatment Market Size, 2017-2028
  6.7.3 Israel Memory Impairment Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Memory Impairment Treatment Market Size, 2017-2028
  6.7.5 UAE Memory Impairment Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 F. Hoffmann-La Roche Ltd.
  7.1.1 F. Hoffmann-La Roche Ltd. Corporate Summary
  7.1.2 F. Hoffmann-La Roche Ltd. Business Overview
  7.1.3 F. Hoffmann-La Roche Ltd. Memory Impairment Treatment Major Product Offerings
  7.1.4 F. Hoffmann-La Roche Ltd. Memory Impairment Treatment Revenue in Global Market (2017-2022)
  7.1.5 F. Hoffmann-La Roche Ltd. Key News
7.2 Suven Life Sciences Ltd.
  7.2.1 Suven Life Sciences Ltd. Corporate Summary
  7.2.2 Suven Life Sciences Ltd. Business Overview
  7.2.3 Suven Life Sciences Ltd. Memory Impairment Treatment Major Product Offerings
  7.2.4 Suven Life Sciences Ltd. Memory Impairment Treatment Revenue in Global Market (2017-2022)
  7.2.5 Suven Life Sciences Ltd. Key News
7.3 Met P Pharma AG
  7.3.1 Met P Pharma AG Corporate Summary
  7.3.2 Met P Pharma AG Business Overview
  7.3.3 Met P Pharma AG Memory Impairment Treatment Major Product Offerings
  7.3.4 Met P Pharma AG Memory Impairment Treatment Revenue in Global Market (2017-2022)
  7.3.5 Met P Pharma AG Key News
7.4 Dart NeuroScience LLC.
  7.4.1 Dart NeuroScience LLC. Corporate Summary
  7.4.2 Dart NeuroScience LLC. Business Overview
  7.4.3 Dart NeuroScience LLC. Memory Impairment Treatment Major Product Offerings
  7.4.4 Dart NeuroScience LLC. Memory Impairment Treatment Revenue in Global Market (2017-2022)
  7.4.5 Dart NeuroScience LLC. Key News
7.5 Omeros Corporation
  7.5.1 Omeros Corporation Corporate Summary
  7.5.2 Omeros Corporation Business Overview
  7.5.3 Omeros Corporation Memory Impairment Treatment Major Product Offerings
  7.5.4 Omeros Corporation Memory Impairment Treatment Revenue in Global Market (2017-2022)
  7.5.5 Omeros Corporation Key News
7.6 Sunovion Pharmaceuticals Inc.
  7.6.1 Sunovion Pharmaceuticals Inc. Corporate Summary
  7.6.2 Sunovion Pharmaceuticals Inc. Business Overview
  7.6.3 Sunovion Pharmaceuticals Inc. Memory Impairment Treatment Major Product Offerings
  7.6.4 Sunovion Pharmaceuticals Inc. Memory Impairment Treatment Revenue in Global Market (2017-2022)
  7.6.5 Sunovion Pharmaceuticals Inc. Key News
7.7 AbbVie Inc.
  7.7.1 AbbVie Inc. Corporate Summary
  7.7.2 AbbVie Inc. Business Overview
  7.7.3 AbbVie Inc. Memory Impairment Treatment Major Product Offerings
  7.7.4 AbbVie Inc. Memory Impairment Treatment Revenue in Global Market (2017-2022)
  7.7.5 AbbVie Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Memory Impairment Treatment Market Opportunities & Trends in Global Market
Table 2. Memory Impairment Treatment Market Drivers in Global Market
Table 3. Memory Impairment Treatment Market Restraints in Global Market
Table 4. Key Players of Memory Impairment Treatment in Global Market
Table 5. Top Memory Impairment Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Memory Impairment Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Memory Impairment Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Memory Impairment Treatment Product Type
Table 9. List of Global Tier 1 Memory Impairment Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Memory Impairment Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Memory Impairment Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Memory Impairment Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Memory Impairment Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Memory Impairment Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Memory Impairment Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Memory Impairment Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Memory Impairment Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Memory Impairment Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Memory Impairment Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Memory Impairment Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Memory Impairment Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Memory Impairment Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Memory Impairment Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Memory Impairment Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Memory Impairment Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Memory Impairment Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Memory Impairment Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Memory Impairment Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Memory Impairment Treatment Revenue, (US$, Mn), 2023-2028
Table 30. F. Hoffmann-La Roche Ltd. Corporate Summary
Table 31. F. Hoffmann-La Roche Ltd. Memory Impairment Treatment Product Offerings
Table 32. F. Hoffmann-La Roche Ltd. Memory Impairment Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Suven Life Sciences Ltd. Corporate Summary
Table 34. Suven Life Sciences Ltd. Memory Impairment Treatment Product Offerings
Table 35. Suven Life Sciences Ltd. Memory Impairment Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Met P Pharma AG Corporate Summary
Table 37. Met P Pharma AG Memory Impairment Treatment Product Offerings
Table 38. Met P Pharma AG Memory Impairment Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Dart NeuroScience LLC. Corporate Summary
Table 40. Dart NeuroScience LLC. Memory Impairment Treatment Product Offerings
Table 41. Dart NeuroScience LLC. Memory Impairment Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Omeros Corporation Corporate Summary
Table 43. Omeros Corporation Memory Impairment Treatment Product Offerings
Table 44. Omeros Corporation Memory Impairment Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Sunovion Pharmaceuticals Inc. Corporate Summary
Table 46. Sunovion Pharmaceuticals Inc. Memory Impairment Treatment Product Offerings
Table 47. Sunovion Pharmaceuticals Inc. Memory Impairment Treatment Revenue (US$, Mn), (2017-2022)
Table 48. AbbVie Inc. Corporate Summary
Table 49. AbbVie Inc. Memory Impairment Treatment Product Offerings
Table 50. AbbVie Inc. Memory Impairment Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Memory Impairment Treatment Segment by Type in 2021
Figure 2. Memory Impairment Treatment Segment by Application in 2021
Figure 3. Global Memory Impairment Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Memory Impairment Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Memory Impairment Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Memory Impairment Treatment Revenue in 2021
Figure 8. By Type - Global Memory Impairment Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Memory Impairment Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Memory Impairment Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Memory Impairment Treatment Revenue Market Share, 2017-2028
Figure 12. US Memory Impairment Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Memory Impairment Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Memory Impairment Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Memory Impairment Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Memory Impairment Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Memory Impairment Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Memory Impairment Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Memory Impairment Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Memory Impairment Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Memory Impairment Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Memory Impairment Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Memory Impairment Treatment Revenue Market Share, 2017-2028
Figure 24. China Memory Impairment Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Memory Impairment Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Memory Impairment Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Memory Impairment Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Memory Impairment Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Memory Impairment Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Memory Impairment Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Memory Impairment Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Memory Impairment Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Memory Impairment Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Memory Impairment Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Memory Impairment Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Memory Impairment Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. F. Hoffmann-La Roche Ltd. Memory Impairment Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Suven Life Sciences Ltd. Memory Impairment Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Met P Pharma AG Memory Impairment Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Dart NeuroScience LLC. Memory Impairment Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Omeros Corporation Memory Impairment Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Sunovion Pharmaceuticals Inc. Memory Impairment Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. AbbVie Inc. Memory Impairment Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)